Effect of maintenance therapy for childhood with acute lymphoblastic leukaemia by combination of methotrexate and 6-mercaptopurine on the liver.
Seven of 30 children with acute lymphoblastic leukaemia (ALL) receiving maintenance therapy (MT) consisting of daily oral 6-mercaptopurine (6MP) and weekly methotrexate (MTX) developed both hepatocellular destruction and intrahepatic cholestasis (with abnormally elevated levels of serum aminotransfe...
Saved in:
Main Authors: | Abid T. Firas (Author), Al-Fakhri F. Ilham (Author) |
---|---|
Format: | Book |
Published: |
College of Pharmacy / Mustansiriyah University,
2005-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Allopurinol adjuvant in acute lymphoblastic leukaemia maintenance treatment
by: Akshay Kamle, et al.
Published: (2022) -
Allopurinol adjuvant in acute lymphoblastic leukaemia maintenance: Benefits and potential risks
by: Duhita Sengupta, et al.
Published: (2024) -
Severe recurrent nocturnal hypoglycemia during chemotherapy with 6-mercaptopurine in a child with acute lymphoblastic leukemia
by: Eun Mi Cho, et al.
Published: (2018) -
Consanguinity and childhood acute lymphoblastic leukaemia: a case-control study
by: Ameer Kakaje, et al.
Published: (2022) -
Effective standardisation and personalisation optimise the management of acute lymphoblastic leukaemia maintenance treatment and improve outcomes
by: Manash Pratim Gogoi, et al.
Published: (2024)